Can Allergy Shots Cause Swollen Lymph Nodes? Immune Response Explained

Allergy shots cause swollen lymph nodes because injected allergen drains through lymphatic channels to the regional axillary (armpit) lymph nodes on the same side as the injection. Once allergen arrives in the node, antigen-presenting cells process it and activate T and B lymphocytes. These immune cells proliferate within the node, causing it to enlarge. This process — called reactive lymphadenopathy or lymph node germinal center activation — is the intended immune modification pathway of immunotherapy. Research published by Akdis and Akdis in the World Allergy Organization Journal documents that successful allergen immunotherapy drives clonal expansion of allergen-specific T regulatory cells, which occurs in the draining lymph nodes. The swelling is evidence this activation is occurring.

Reactive lymph node swelling from allergy shots typically resolves within 2–4 weeks as the immune response to that dose completes. Patients in the build-up phase may notice that nodes swell again after each weekly injection and then partially subside before the next dose, following the rhythm of allergen administration. Once patients reach the maintenance phase, with stable monthly doses and a more tolerant immune response, lymph node activity typically decreases. Swelling that persists beyond 4 weeks without evidence of resolution, or that continues growing rather than shrinking, warrants evaluation from your allergist. Persistent lymphadenopathy beyond 6 weeks from any cause should prompt medical assessment to rule out non-immunotherapy explanations.

Mild ipsilateral axillary lymph node swelling — soft, mobile, mildly tender nodes in the armpit on the same side as your injection — is not cause for concern and requires no intervention. It is a sign of appropriate immune activation. You should contact your allergist if the swollen nodes have any of the following characteristics: size greater than 2 cm, hard or fixed texture, supraclavicular location (above the collarbone), bilateral involvement (both sides), or persistence beyond 4 weeks. Additionally, B symptoms — fever, night sweats, or unexplained weight loss accompanying lymph node swelling — require urgent medical evaluation regardless of allergy shot timing. These features are not consistent with immunotherapy-related lymphadenopathy.

Yes — the underlying mechanism is essentially identical. COVID-19 mRNA vaccines are injected subcutaneously or intramuscularly in the upper arm, and the antigen drains to ipsilateral axillary lymph nodes, causing reactive enlargement. Research by Klein et al. published in the New England Journal of Medicine documented axillary lymphadenopathy in 5–16% of mRNA vaccine recipients. The same immunological principle applies to allergen immunotherapy injections: any subcutaneous antigen introduction can cause regional lymph node activation as immune cells process the injected material. This post-vaccine experience has actually helped patients and clinicians understand that axillary lymphadenopathy after arm injections is a normal immune response, not a warning sign.

Allergy shots should not cause lymph node swelling in locations other than the ipsilateral axillary (same-side armpit) region. Allergen injected into the upper arm drains through predictable lymphatic channels to axillary nodes — not to cervical (neck), inguinal (groin), or bilateral locations. Lymph node swelling in other locations, particularly supraclavicular nodes (above the collarbone), bilateral nodes, or nodes in completely unrelated anatomical regions, is not consistent with post-injection reactive lymphadenopathy and requires evaluation for other causes. Supraclavicular lymphadenopathy in particular is considered a red flag in clinical practice guidelines and should be evaluated promptly regardless of allergy shot history.